Phase II evaluation of chlorozotocin in patients with malignant melanoma.
作者信息
Houghton A N, Camacho F J, Gralla R J, Wittes R
出版信息
Cancer Treat Rep. 1981 Jul-Aug;65(7-8):705-6.
PMID:6454487
Abstract
摘要
相似文献
1
Phase II evaluation of chlorozotocin in patients with malignant melanoma.氯脲霉素用于恶性黑色素瘤患者的II期评估。
Cancer Treat Rep. 1981 Jul-Aug;65(7-8):705-6.
2
Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group report.氯脲霉素治疗恶性黑色素瘤的II期研究：一项东南癌症研究组报告
Cancer Treat Rep. 1982 Jun;66(6):1431-3.
3
Chlorozotocin: phase II evaluation in patients with advanced sarcomas.氯脲霉素：晚期肉瘤患者的II期评估
Cancer Treat Rep. 1981 May-Jun;65(5-6):513-4.
4
Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanoma.美登素与氯脲霉素治疗播散性恶性黑色素瘤患者的II期研究。
Cancer Treat Rep. 1980 Apr-May;64(4-5):721-3.
5
Phase II trial of chlorozotocin in malignant melanoma, breast cancer, and other solid tumors.氯脲霉素用于恶性黑色素瘤、乳腺癌及其他实体瘤的II期试验。
Cancer Treat Rep. 1982 May;66(5):1229-30.
6
7
Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma.
Cancer Treat Rep. 1982 Feb;66(2):371-3.
8
Phase I trial of chlorozotocin: attempted amelioration of myelotoxicity by glucose administration.氯脲霉素的I期试验：通过给予葡萄糖尝试改善骨髓毒性。
Cancer Treat Rep. 1981 Jul-Aug;65(7-8):647-50.
9
Phase II study of chlorozotocin in advanced breast cancer.氯脲霉素治疗晚期乳腺癌的II期研究。
Cancer Treat Rep. 1981 May-Jun;65(5-6):537-8.
10
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma.氯脲霉素用于晚期支气管源性癌的II期评估。
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2105-6.
Zotero 插件